MAPT and Alzheimer disease: We observed that the overall expression of PLD1 is significantly increased in the AD group compared to the control in both the experimental slides used for Aβ (Figure 1B, ** p = 0.0022) and tau (Figure 1F, ** p = 0.0022) co-staining with PLD1.